CHRS
Coherus BioSciences Inc
1.20$
+2.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Coherus BioSciences Inc (CHRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -139 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | 15 | -24 | -108 | -253 | -200 | -159 | 28 | 154 | -37 | -241 | -175 | -20 | -139 | |
| 0.2 | 0.4 | 0.7 | 1.9 | 3.0 | 3.4 | 3.2 | 3.3 | 2.9 | 3.5 | 3.7 | 3.8 | 5.3 | 3.9 | |
| 0.4 | 2.0 | 11 | 17 | 27 | 36 | 35 | 34 | 38 | 51 | 51 | 43 | 28 | 17 | |
| – | – | 30 | 22 | 30 | 38 | 35 | 34 | 38 | 250 | 83 | – | – | – | |
| 12 | 41 | 28 | 91 | -159 | -5.1 | 10 | -114 | -35 | 42 | -79 | -37 | 56 | -5.8 | |
| 1.8 | 0.4 | 2.8 | 6.2 | 6.5 | 4.6 | 0.8 | 13 | 7.2 | 1.3 | 2.0 | 0.3 | 0.0 | 0.0 | |
| -1.8 | -0.4 | -0.5 | -6.9 | -6.5 | -4.4 | -1.2 | -13 | -14 | -138 | -167 | 145 | 230 | 375 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 72 | 20 | 1.8 | 3.7 | – | – | – | |
| – | – | 0.0 | 11 | 2.6 | -0.5 | 3.7 | -0.8 | -0.9 | -1.8 | -3.7 | -3.6 | – | – | |
| – | – | 100 | 100 | 100 | 73 | 73 | 73 | 222 | -0.7 | 50 | 0.0 | -223 | -281 | |
| 27 | 10.0 | 136 | 123 | 226 | 207 | 105 | 89 | 224 | 52 | 54 | 70 | -187 | -274 | |
| 6.9 | 25 | 111 | 7.8 | -33 | 2.0 | -55 | 105 | 364 | -124 | -354 | 39 | 23 | -37 | |
| -20 | 15 | -27 | -114 | -259 | -205 | -160 | 15 | 147 | -39 | -243 | -175 | -20 | -139 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.